- Home
- PRI vs RGC Comparison
PRI vs RGC Comparison
Compare PRI & RGC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PRI
- RGC
- Stock Information
- Founded
- PRI 1927
- RGC 2014
- Country
- PRI United States
- RGC Hong Kong
- Employees
- PRI N/A
- RGC N/A
- Industry
- PRI Life Insurance
- RGC Medicinal Chemicals and Botanical Products
- Sector
- PRI Finance
- RGC Health Care
- Exchange
- PRI Nasdaq
- RGC Nasdaq
- Market Cap
- PRI 8.6B
- RGC 8.4B
- IPO Year
- PRI N/A
- RGC 2021
- Fundamental
- Price
- PRI $266.10
- RGC $15.52
- Analyst Decision
- PRI Buy
- RGC
- Analyst Count
- PRI 7
- RGC 0
- Target Price
- PRI $316.00
- RGC N/A
- AVG Volume (30 Days)
- PRI 135.5K
- RGC 228.2K
- Earning Date
- PRI 11-05-2025
- RGC 10-24-2025
- Dividend Yield
- PRI 1.56%
- RGC N/A
- EPS Growth
- PRI 61.36
- RGC N/A
- EPS
- PRI 20.26
- RGC N/A
- Revenue
- PRI $3,220,913,000.00
- RGC N/A
- Revenue This Year
- PRI $4.38
- RGC N/A
- Revenue Next Year
- PRI $5.62
- RGC N/A
- P/E Ratio
- PRI $13.17
- RGC N/A
- Revenue Growth
- PRI 7.56
- RGC N/A
- 52 Week Low
- PRI $230.98
- RGC $0.09
- 52 Week High
- PRI $307.91
- RGC $83.60
- Technical
- Relative Strength Index (RSI)
- PRI 45.88
- RGC 42.63
- Support Level
- PRI $262.06
- RGC $16.00
- Resistance Level
- PRI $274.01
- RGC $19.30
- Average True Range (ATR)
- PRI 6.32
- RGC 1.60
- MACD
- PRI -0.82
- RGC -0.02
- Stochastic Oscillator
- PRI 33.03
- RGC 7.01
About PRI Primerica Inc.
Primerica Inc is a provider of financial services to middle-income households in the United States and Canada. The company offers life insurance, mutual funds, annuities, and other financial products, distributed on behalf of third parties. Primerica has three main subsidiaries: Primerica Financial Services, a marketing company; Primerica Life Insurance Company, a principal life insurance underwriting entity; and PFS Investments, which offers investment and savings products, brokerage services, and registered investment advisory. It has three segments Term Life Insurance; Investment and Savings Products; and Corporate and Other Distributed Products. Geogriphically, it derives a majority of its revenue from the United States.
About RGC Regencell Bioscience Holdings Limited
Regencell Bioscience Holdings Ltd is a bioscience company focusing on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degenerations, specifically ADHD and ASD, and infectious diseases affecting people's immune systems.